Summary for topics from general and orthopaedic surgery for medicine
Course
General and orthopaedic surgery
Institution
University Of Southampton (UOS)
Summary of 53 topics relevant to the model general and orthopaedic surgery as a third but also fifth year medical student.
All topics are structured as possible in: aetiology / risk factors, pathophysiology, classifications, symptoms, investigations, management / therapy, complications, preventio...
Upper gastrointestinal conditions
Gastric cancer
Risk Factor / Aetiology
- Highest incidence in South Korea, Mongolia and Japan, more common in males, older people
- Exogenous risk factors: diet rich in nitrates / salt, H. pylori infection, nicotine use, Epstein-Barr
virus, low socioeconomic status, obesity
- Endogenous risk factors:
➔ Gastric conditions: chronic atrophic gastritis and pernicious anaemia, Achlorhydria (due to
Menetrier disease), gastric ulcers. Partial gastrectomy, adenomatous gastric polyps,
gastroesophageal reflux disease
➔ Hereditary factors: positive family history, blood type A, hereditary nonpolyposis colorectal
cancer
Pathophysiology / Classification
- H. pylori: triggers inflammation of mucosa causing atrophy and intestinal metaplasia
Gastric adenocarcinoma (95%):
- Commonly located on lesser curvature, arises from
glandular cells in stomach
- Lauren classification
➔ Intestinal type gastric CA: typically localised,
polypoid glandular formation, similar to an
ulcerative lesion with clear raised margins,
common located on the lesser curvature
➔ Diffuse type gastric CA: no clear border, spreads
earlier, infiltrative growth, diffuse spread in gastric
wall, linits plastica (gastric wall thickening and leather bottle appearance), composed of
signet ring cells (worse prognosis, round cells filled with mucin with a flat nucleus in the cell
periphery), associated with E-cadherin mutation
➔ Intermediate type: least common type
Other gastric cancer types:
- GI stromal tumours (GISTs): malignant mesenchymal neoplasm of the GI tract that arises from
interstitial cells of Cajal or precursors, treatment involves surgical removal and treatment with
tyrosine kinase inhibitors such as imatinib or dasatinib
- Neuroendocrine tumours (including carcinoids): start in endocrine cells of stomach, grow slowly
and normally don’t spread
- Lymphomas: start in immune cells like MALT lymphoma (95% caused by H. pylori)
- Others: squamous cell carcinomas, small cell carcinomas, leiomyosarcomas
Signs & Symptoms
Early stage
- Often asymptomatic, loss of appetite /
nausea
Later stages: presentation with advanced
stages in 50%
2Virchow node 1Sister Mary Joseph node
Page 3 of 144
, Year 3 - Surgery | Thalia Börsch
- General signs: weight loss (may be
due to decreased calorie intake due to
pain), signs of chronic iron deficiency
anaemia, palpable tumour
- Signs of gastric outlet obstruction:
dyspepsia, dysphagia, abdominal
epigastric pain, early satiety, vomiting
Signs of upper Gi bleeding:
haematemesis, melena
- Signs of metastatic disease: 3Malignant acanthosis nigricans 4Leser-Trelat sign
hepatomegaly, ascites, left
supraclavicular adenopathy (Virchow node), palpable umbilical nodule (Sister Mary Joseph
node), palpable mass on DRE (Blumer shelf), ovarian mass (Krukenberg tumour) plus
complications
- Paraneoplastic syndromes: Leser-Trelat sign, malignant acanthosis nigricans
Investigations
- Confirmatory tests: upper endoscopy with biopsy, upper GI series (barium studies)
- Labs: anaemia, positive faecal occult blood test, renal and liver function tests, serologic markers
(tumour markers like CA 72-4, CA 19-9, CEA; TNF-alpha), HER2 testing
- Imaging:
➔ Endosonography: depth of tumour invasion, lymph node involvement
➔ Abdominal ultrasound
➔ CT scan (abdomen, pelvis, thorax): lymph node involvement, detection of distant
metastases
➔ PET-CT/diagnostic laparoscopy: for occult metastases that could have been missed during
endoscopy or on CT scan
Differential diagnosis
Gastric conditions: gastric ulcer, Gastroesophageal reflux disease (GERD), Menetrier disease, non-
ulcer dyspepsia
Management
Early-stage disease
- Endoscopic mucosal tumour resection
- Subtotal or total gastrectomy
- H. pylori infection treatment / eradication
Late-stage disease
- Perioperative chemotherapy or radiotherapy: as neoadjuvant / adjuvant therapy, Trastuzumab
is indicated for HER2-positive gastric adenocarcinomas
- Surgery:
➔ Total gastrectomy and lymphadenectomy: complete resection of stomach with blind closure
of the proximal duodenum, resection of the lesser and greater omentum, radical
lymphadenectomy
➔ Subtotal gastrectomy: resection of body ad pylorus of stomach with blind closure of the
duodenal stump, radical lymphadenectomy
➔ Roux-en-Y gastric bypass: surgical technique used in the reconstruction of gastric passage
to prevent GI obstruction after gastrectomy / bariatric surgery
Page 4 of 144
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller thalia7. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $11.29. You're not tied to anything after your purchase.
